expression of several protective proteins in resistant tumour cells, such as MnSOD
, endogenous TNF [7] , major heat shock protein hsp70 [8] , A20 zinc finger protein [9] , However, these proteins confer only partial protection against TNF-cytotoxicity, suggesting that additional resistance mechanisms exist.
The actin cytoskeleton proteins appear to be regulated in response to several cell death signals including TNF [10] . Thus, gelsolin and ␣-fodrin were identified as caspase-3 substrate in cells stimulated by Fas (TNF receptor superfamily, member 6) [11] and respectively. Moreover, treatment of cells with cisplatin increased phosphorylation of ␣-adducin, its dissociation from the cytoskeleton and its cleavage by caspase-3 [13] . Koss et al. provided [14] . More recently, report from Bieler et al. revealed that an intact actin cytoskeleton was required for PKB/Akt to prevent TNF-induced death [15] . Taken together these studies suggest that the cytoskeleton can no longer be considered as a simple structural framework playing a role in cell shape and motile events. Rather, the actin cytoskeleton seems to play an important role in the execution phase of cell death. [16] . 
evidence that the response of endothelial cells to TNF-␣ may involve the phosphorylation of cytoskeleton proteins Ezrin, Radixin and Moesin

Thus, identification of novel cytoskeleton genes which contribute to the regulation of the response to TNF-␣ may provide new perspective to the therapeutic use of TNF as an anticancer agent. Here, we used DNA microarray methodology to investigate the cytoskeleton gene expression profile associated with the acquisition of cell resistance to TNF-␣ in breast carcinoma cell line. We provided evidence that TNF-␣ resistance correlates with the acquisition of mesenchymal cell phenotype and a reorganization of the actin cytoskeleton. Our data highlight the up-regulation of a group of F-actin stabilizing genes in resistant cells. Interestingly, we found that the F-actin bundling protein L-plastin is necessary and sufficient to confer, in a phosphorylation-dependent manner, cell resistance to TNF-␣. This study revealed a novel unexpected function for the L-plastin in the mechanism of cell resistance to TNF-␣.
Materials and methods
Reagents and antibodies
Recombinant human TNF-␣ was from R&D Systems (Oxon, UK). GF 109203X, H89, Gö6976 and Fostriecin were from Calbiochem (Leuven, Belgium). C2-ceramide was from Sigma (Bornem, Belgium). Rabbit anti-Lplastin and anti-serine-5 phosphorylated L-plastin (ser-5P) antibodies have been previously described
Mouse monoclonal anti-L-plastin antibody (Clone LPL4A.1) was from Abcam (Cambridge, UK). Mouse anti-Ecadherin and anti-␤-catenin were from BD-Biosciences (Erembodegem, Belgium). Mouse anti-cytokeratin-18 (DC-
Indirect immunofluorescence
Cells were fixed with 3% paraformaldehyde, detergent permeabilized with 0.4% Triton X-100, and labelled as previously described [16] . 
Immunoblotting analysis
Protein extracts from cells were prepared as previously described [16] [19] .
RT-PCR and quantitative RT-PCR (qRT-PCR)
RT-PCR and qRT-PCR analysis of L-pastin mRNA were performed using SuperScript III One-Step RT-PCR kit (Invitrogen). L-plastin primers were: forward 5Ј-ttggcacccaacactccta-3Ј and reverse 5Ј-ccagggctttgtttatccag-3Ј primers. GAPDH gene was used as an endogenous control. GAPDH primers were: forward 5Ј-agccacatcgctcagacac-3Ј and reverse 5Ј-gcccaatacgaccaaatcc-3Ј.
Results and discussion
Cell resistance to TNF-␣ correlates with a reorganization of the actin cytoskeleton and the acquisition of a mesenchymal phenotype 
TNF-␣ resistance is accompanied by changes in the repertoire of expressed genes involved in epithelial cell plasticity and actin cytoskeleton organization
To determine differentially expressed actin cytoskeleton-related genes in 1001 and MCF-7 cells, we performed gene expression profiling experiments using an actin cytoskeleton dedicated microarray termed Actichip [18] [25] ).
The higher expression of L-plastin has been confirmed at mRNA and protein levels in 1001 cells (Fig. 2A) [16] [26] . [19] .
Gene profiling experiments were performed using the Actichip microarray as previously described in 'Material and methods'. A score (d) value is assigned to each gene based on its change in expression relative to the standard deviation obtained by repeated measurements for the gene. Genes with high score are deemed as significantly regulated. A log2 ratio of 1 corresponds to a two-fold change in the expression level of a transcript. Positive log ratios correspond to up-regulated genes and negative log ratios (highlighted in grey) correspond to down-regulated genes in 1001 cells when compared to MCF-7.
TNF-␣ (Fig. 2B). Accordingly, as resulted by the cell viability assay, L-plastin siRNA transfection in 1001 cells yielded in a 40% decrease of cells viability after TNF-␣ treatment when compared to that of untrasfected or GFP-siRNA transfected 1001 cells. The TNF resistance of the remaining 60% cells would be related to either the efficiency of transfection and/or the transient effect of the Lplastin silencing during the viability assay (Fig. 2C). To further confirm the role of L-plastin in the regulation of TNFmediated cell death, we overexpressed L-plastin-GFP in MCF-7 cells. The high efficiency of transfection was monitored by fluorescence microscopy and the overexpression of L-plastin GFP was confirmed by immunoblot (Supporting Information data 2). Interestingly, L-plastin overexpression was sufficient to significantly increase (50%) viability of MCF-7 cells after TNF-treatment (Fig. 2D). It is worthy to note that 44% of control untransfected cells were resistant to TNF-␣. We could therefore assume that those cells represent a sub-population of MCF-7 cells expressing high level of L-plastin. This hypothesis is supported by our data in the Fig. 2B demonstrating that L-plastin expressing MCF-7 cells resist to the cytotoxic effect of TNF-␣. Notably, neither knockdown of L-plastin in resistant 1001 cells nor its overexpression in MCF-7 cells caused detectable phenotypic changes and epithelial-to-mesenchymal transition markers regulations (Supporting Information data 3). Based on this result, we may speculate that L-plastin acts independently of the EMT process. This result is in agreement with previous findings suggesting that the expression of L-plastin does not induce profound cytoskeleton reorganization but rather contributes to changes of the cortical cytoskeleton linked to membrane bound signalling complexes
Acquisition of resistance to TNF-␣ requires L-plastin phosphorylation
It has been reported that the activity of L-plastin is regulated by phosphorylation on Ser5 residue [16]. Here, we found that transfected L-plastin-GFP in MCF-7 and endogenous L-plastin in 1001 cells are highly phosphorylated on ser5 (Fig. 3A), suggesting a critical role for this phosphorylation in TNF resistance. To test this hypothesis, we transfected MCF-7 cells with WT or ser5 mutated to Alanine (S5/A) unphosphorylable-L-plastin-GFP and performed TNF-␣ cell viability assays. Expression of S5/A-L-plastin-GFP in TNF-sensitive MCF-7 cells had no effect on their resistance to TNFmediated cell death (Fig. 3B). In contrast, a significant increase in TNF-␣ resistance was observed in MCF-7 cells expressing WT-Lplastin-GFP. Altogether, our data provide evidence that phosphorylation of L-plastin on ser5 is critical for the acquisition of resistance to TNF-␣. Previous findings have demonstrated that L-plastin may contribute to the stabilization of the cell cortex, or alternatively, contribute to the assembly of receptor mediated complexes
In this regard, the involvement of L-plastin in TNF-receptors internalization seems to be unlikely, because we have previously reported that 1001 and MCF-7 cells displayed comparable levels of either p55 TNF receptor expression or NF-B activation
The nature of kinases involved in phosphorylation of L-plastin is still controversial. Although several studies support the direct phosphorylation of L-plastin by PKA [16, 27] , the implication of PKC in L-plastin phosphorylation remains to be confirmed [24, 28] . Moreover, Basu et al. provided evidence that a differential sensitivity of breast cancer cells to TNF-␣ could be related to a differential expression level of PKCs [29] . Consistent with these studies, we investigated the relative contribution of PKA and PKC in L-plastin phosphorylation, by using H89 and Gö6976, agents which selectively inhibit PKA and conventional PKC isozymes, respectively. Interestingly, even at high concentrations, (5 M Cell viability was determined using the MTT assay and calculated as described in [19] . (WT) . Immunoblot analysis was performed using an anti-ser5 phosphorylated L-plastin specific antibody (Ser5-P) [16] [30, 31] .
Results are given as the mean Ϯ S.D. of three independent experiments. (D) Effect of L-plastin overexpression on MCF-7 cell sensitivity to TNF-␣. Cells were transfected with WT L-plastin-GFP cDNA encoding pEGFP-C vector. Cell viability of control untransfected (Ctrl) or L-plastin-GFP expressing MCF-7 cells in the presence of TNF-␣ was determined as described in (C). Results are expressed as the mean Ϯ S.D. of three independent experiments. (D) Expression of PKC-␦ and -in MCF-7 and 1001 cells. Immunoblot analysis was performed on total protein extracts (50 g) using an anti-PKC-␦ (Upper panel), an anti-PKC-(middle panel), or an anti-actin (lower panel) antibody. (E) Knockdown of PKC-␦ decreased L-plastin phosphorylation in
(upper panel), an anti-L-plastin (middle panel) or an anti-GAPDH (lower panel). The higher band (upper and middle panels) corresponds to the transfected L-plastin fused to GFP (L-plastin-GFP) and the lower band corresponds to endogenous L-plastin (L-plastin). (B) Unphosphorylable L-plastin does not confer resistance to TNF-␣ in MCF-7 cells. Cell viability assay was performed after 72 hrs of TNF-␣ treatment (75 ng/ml) on untransfected (UT) and transfected MCF-7 cells with either GFP (GFP), WT L-plastin-GFP (WT) or unphosphorylable L-plastin-GFP (S5/A). The transfection efficiency was nearly identical in cells (
PKC-␦ is the major kinase involved in L-plastin phosphorylation
Non-conventional PKC represents a family of seven isozymes that have been categorized into two groups: the new or novel PKCs (⑀, ␦, and ) and the atypical PKCs (-, -and -) . Although MCF-7 cells expressed the majority of non-conventional PKCs isozymes [29] , PKC-␦ and-have been described as regulators of actin cytoskeleton and TNF-␣ signalling [32] [33] [34] [35] . Immunoblot analysis showed no difference in the expression level of PKC-␦ and -isozymes in both MCF-7 and 1001 cells (Fig. 3D) (Fig. 3E) . (Fig. 3F) . Collectively, these results provided evidence that ceramide induces L-plastin dephosphorylation by a mechanism involving, at least in part, the activity of PP2A. Our data are consistent with those recently described by Zeidan et al. demonstrating that the activation of the acid-sphingomyelinase (ASMase)/ceramide pathway by cisplatin in MCF7 cells induces the dephosphorylation of ezrin, leading to cytoskeleton rearrangements and increased cell motility [37] . We, and others, have previously shown that L-plastin participates in cancer cell invasion [16, 38] (Fig. 4A) . Interestingly, MCF-7/TamR and MDA-MB435s are both resistant to TNF-␣ (Fig. 4B) . In contrast, L-plastin expression was not detected in the T47D cell line which is sensitive to TNF-␣ (Fig. 4A and B 
Regulation of L-plastin phosphorylation via the sphingomyelin/ceramide pathway
